Lenexa company wins approval for immunotherapy treatment for bone cancer in dogs March 19, 2025 by Brian Kaberline Full approval from the U.S. Department of Agriculture culminates 10 years of efforts to bring a new type of cancer treatment to market for dogs — and is a boon to those seeking to use similar treatments in humans.